1373 studies found for:    "Liver Neoplasms"
Show Display Options
RSS Create an RSS feed from your search for:
"Liver Neoplasms"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting PET/CT-Assessment of Liver Tumor Ablation
Conditions: Liver Tumor;   Liver Neoplasms
Interventions: Radiation: N-13 ammonia;   Device: PET/CT scanner
2 Recruiting Fusion Guided Thermal Ablation Combined With External Beam Radiation for Hepatic Neoplasms
Conditions: Liver Neoplasms;   Hepatic Cancer;   Liver Cancer
Interventions: Procedure: Thermal Ablation;   Procedure: Standard External Beam Radiation Therapy
3 Recruiting Sorafenib and TRC105 in Hepatocellular Cancer
Conditions: Hepatoma;   Liver Neoplasms;   Adenoma, Liver Cell;   Carcinoma, Hepatocellular;   Liver Neoplasms, Experimental
Interventions: Drug: TRC 105;   Drug: Sorafenib
4 Recruiting Trametinib in Combination With Sorafenib in Patients With Advanced Hepatocellular Cancer
Conditions: Hepatocellular Cancer;   Liver Cancer
Interventions: Drug: Trametinib;   Drug: Sorafenib
5 Recruiting Dose Escalation Study of OMP-54F28 in Combination With Sorafenib in Patients With Hepatocellular Cancer
Conditions: Hepatocellular Cancer;   Liver Cancer
Intervention: Drug: OMP-54F28 with Sorafenib
6 Recruiting Tremelimumab With Chemoembolization or Ablation for Liver Cancer
Conditions: Liver Cell Caricinoma;   Liver Cancer;   Hepatocellular Carcinoma;   Liver Neoplasms
Interventions: Drug: Tremelimumab;   Procedure: TACE;   Procedure: Radiofrequency Ablation (RFA)
7 Completed Oxaliplatin in Treating Patients With Liver Cancer
Conditions: Adult Primary Hepatocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Localized Unresectable Adult Primary Liver Cancer;   Recurrent Adult Primary Liver Cancer
Interventions: Drug: oxaliplatin;   Other: laboratory biomarker analysis
8 Withdrawn SCH 66336 With or Without Gemcitabine Followed by Surgery Compared With Surgery Alone in Treating Patients With Primary Liver Cancer
Condition: Liver Cancer
Interventions: Drug: gemcitabine hydrochloride;   Drug: lonafarnib;   Procedure: conventional surgery
9 Completed
Has Results
Bevacizumab and Erlotinib in Treating Patients With Advanced Liver Cancer
Conditions: Adult Primary Hepatocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Localized Unresectable Adult Primary Liver Cancer;   Recurrent Adult Primary Liver Cancer
Interventions: Biological: bevacizumab;   Drug: erlotinib hydrochloride
10 Withdrawn Study of Pegylated Liposomal Doxorubicin and Temsirolimus in Patients With Advanced Hepatocellular Cancer
Condition: Liver Neoplasms
Intervention: Drug: Temsirolimus 25mg and Pegylated liposomal doxorubicin 25mg/m2
11 Completed Chemotherapy in Treating Children With Liver Cancer
Condition: Liver Cancer
Interventions: Drug: carboplatin;   Drug: cisplatin;   Drug: doxorubicin hydrochloride;   Procedure: conventional surgery
12 Completed A Phase I Study of Isolated Hepatic Portal and Arterial Perfusion (IHP) With Escalating Dose Melphalan for Primary or Metastatic Unresectable Cancers of the Liver
Conditions: Liver Neoplasms;   Neoplasm Metastasis
Interventions: Procedure: Isolated hepatic portal and arterial perfusion;   Drug: Melphalan
13 Recruiting TheraSphere® for Treatment of Unresectable Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma;   Liver Cancer;   Liver Neoplasm;   Primary Liver Cancer
Intervention: Device: TheraSphere
14 Completed A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the Liver
Conditions: Colorectal Neoplasm;   Liver Neoplasm;   Neoplasm Metastasis
Interventions: Drug: Melphalan;   Drug: Floxuridine;   Drug: Leucovorin
15 Terminated Evaluation of Intra-operative Ultrasound Contrast Enhancement in the Evaluation of Liver Tumors
Condition: Liver Tumors
Intervention: Drug: Definity®
16 Active, not recruiting CS1008- in Combination With Sorafenib Compared to Sorafenib Alone in Subjects With Advanced Liver Cancer
Conditions: Advanced Hepatocellular Carcinoma;   Liver Cancer;   Hepatic Cancer;   Liver Neoplasms
Interventions: Drug: CS-1008;   Drug: sorafenib
17 Completed Heat Therapy in Treating Patients With Unresectable Primary or Metastatic Liver Cancer
Conditions: Liver Cancer;   Metastatic Cancer
Intervention: Procedure: Radiofrequency Ablation
18 Unknown  Antineoplaston Therapy in Treating Patients With Primary Liver Cancer
Condition: Liver Cancer
Intervention: Drug: antineoplaston A10
19 Completed Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases
Conditions: Colorectal Cancer;   Islet Cell Tumor;   Liver Cancer;   Metastatic Cancer;   Neuroendocrine Carcinoma
Interventions: Drug: isolated perfusion;   Drug: melphalan;   Procedure: conventional surgery
20 Withdrawn Biomarkers in Stored Tumor Samples From Younger Patients With Liver Cancer
Condition: Liver Cancer
Interventions: Genetic: comparative genomic hybridization;   Genetic: molecular genetic technique;   Genetic: mutation analysis;   Genetic: polymerase chain reaction;   Genetic: proteomic profiling;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Other: mass spectrometry;   Other: medical chart review

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years